Results 151 to 160 of about 5,734 (165)

[Multidisciplinary expert consensus on tophus damage grading and surgical treatment (2025 edition)]. [PDF]

Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi
Wound Repair Professional Committee of Chinese Medical Doctor Association.
europepmc   +1 more source

[Role and Mechanism of Hyaluronic Acid-modified Milk Exosomes 
in Reversing Pemetrexed Resistance in Lung Adenocarcinoma Cells]. [PDF]

Zhongguo Fei Ai Za Zhi
Wu L, Lei J, Li H.
europepmc   +1 more source

[Guardians of Immune Tolerance: Regulatory T Cells]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Ming K, Zhang H, Hu H.
europepmc   +1 more source

[Research progress on mechanisms and clinical management of comorbid constipation in children with autism spectrum disorder]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Ding JJ, DU DY, Li P.
europepmc   +1 more source

[Molecular Epidemiology and Fluconazole Resistance Mechanisms in <i>Candida tropicalis</i> Isolates From Bloodstream Infections in Sichuan, China]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Chen W, Hou J, Peng L, Kang M, Ma Y.
europepmc   +1 more source

[Efficacy and safety of lusutrombopag monotherapy for cyclosporine A-refractory, transfusion-dependent non-severe aplastic anemia]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Zhou YX, Wei YY, Liu ZW, Yang C, Chen M, Han B.   +5 more
europepmc   +1 more source

[Advancing the development of hematology care units to enhance hematology‑specific critical care capacity]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Fan SJ, Li HT, Zhang X.
europepmc   +1 more source

[Traditional Chinese medicine for regulating glycolysis to remodel the tumor immune microenvironment: research progress and future prospects]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
He S, Liu Y, Qin M, He C, Jiang W, Wang Y, Tan S, Sun H, Sun H.   +8 more
europepmc   +1 more source

[Phase Ⅲ, multicenter, randomized, double-blinded, positive-controlled trial on the efficacy and safety of maribavir compared with valganciclovir in the treatment of post-transplant cytomegalovirus infection: Subgroup analysis of AURORA Trial in the Chinese population]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Xuan L, Huang H, Xu LP, Fu YW, Chen F, Wang Y, Wang SQ, Dong L, Wu JY, Wu DP.   +9 more
europepmc   +1 more source

[Comprehensive considerations for the diagnosis, treatment, and management of osteogenesis imperfecta]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Lyu XH, Dong J.
europepmc   +1 more source